Skip to main content

Perspective Therapeutics, Inc.

CATX
Exchange
NYSE
Industry
Pharmaceutical Preparations
SEC CIK
0000728387

In the last 90 days, Perspective Therapeutics, Inc. insiders filed 0 open-market purchases and 5 sales; 131 institutions reported holding it in 13F filings for Q2 2026, worth $297.6M in total; no superinvestor holds it.

Q4 2022 vs. Q3 2022

How the institutions holding Perspective Therapeutics, Inc. changed between Q3 2022 and Q4 2022.

All holders in Q4 2022All holders in Q3 2022

13F holders of CATX: Q3 2022 compared with Q4 2022
MeasureQ3 2022Q4 2022Change
Holders3548+13
Shares16.1M17.2M+1.16M (+7.2%)
Value$3.70M$4.26M+$559.0K (+15.1%)

New holders (15)

Institutions that held Perspective Therapeutics, Inc. at the end of Q4 2022 but not at the end of Q3 2022.

Institutions new to CATX in Q4 2022
InstitutionSharesValue% of portfolio
HighTower Advisors, LLC1,147,038$283.0K0.00%
Cetera Investment Advisers85,000$21.0K0.00%
Virtu Financial LLC67,004$17.0K0.00%
Jane Street Group, LLC49,436$12.2K0.00%
JDM Financial Group LLC35,000$8.65K0.01%
LPL Financial LLC34,138$8.44K0.00%
HRT Financial LP30,189$7.00K0.00%
Tower Research Capital LLC (TRC)21,512$5.00K0.00%
Wealth Advisors of Iowa, LLC20,000$4.94K0.00%
Susquehanna International Group, LLP19,354$4.78K0.00%
Two Sigma Securities, LLC16,327$4.03K0.00%
Mendota Financial Group, LLC15,000$3.71K0.00%
FMR LLC6,266$1.55K0.00%
Advisory Services Network, LLC1,000$2470.00%
Bank of America Corp336$820.00%

Sold out (2)

Institutions that held Perspective Therapeutics, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.

Institutions that sold out of CATX in Q4 2022
InstitutionShares, Q3 2022Value, Q3 2022
Bard Associates Inc667,700$154.0K
WCG Wealth Advisors LLC34,022$8.00K